Interleukin-22 mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury

Wei Chen(Eon Corporation (United States)), Dianwen Ju(Fudan University)
bioRxiv (Cold Spring Harbor Laboratory)
August 5, 2020
Cited by 0


Related Papers